JP2022551499A5 - - Google Patents

Info

Publication number
JP2022551499A5
JP2022551499A5 JP2022521440A JP2022521440A JP2022551499A5 JP 2022551499 A5 JP2022551499 A5 JP 2022551499A5 JP 2022521440 A JP2022521440 A JP 2022521440A JP 2022521440 A JP2022521440 A JP 2022521440A JP 2022551499 A5 JP2022551499 A5 JP 2022551499A5
Authority
JP
Japan
Prior art keywords
approximately
weight
formulation according
cps
ear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022521440A
Other languages
English (en)
Japanese (ja)
Other versions
JP7680653B2 (ja
JP2022551499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054770 external-priority patent/WO2021072063A1/en
Publication of JP2022551499A publication Critical patent/JP2022551499A/ja
Publication of JP2022551499A5 publication Critical patent/JP2022551499A5/ja
Priority to JP2025051291A priority Critical patent/JP2025098165A/ja
Application granted granted Critical
Publication of JP7680653B2 publication Critical patent/JP7680653B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022521440A 2019-10-11 2020-10-08 耳用製剤、方法およびデバイス Active JP7680653B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025051291A JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962914301P 2019-10-11 2019-10-11
US62/914,301 2019-10-11
PCT/US2020/054770 WO2021072063A1 (en) 2019-10-11 2020-10-08 Otic formulations, methods and devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025051291A Division JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Publications (3)

Publication Number Publication Date
JP2022551499A JP2022551499A (ja) 2022-12-09
JP2022551499A5 true JP2022551499A5 (enExample) 2023-09-13
JP7680653B2 JP7680653B2 (ja) 2025-05-21

Family

ID=75383696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521440A Active JP7680653B2 (ja) 2019-10-11 2020-10-08 耳用製剤、方法およびデバイス
JP2025051291A Pending JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025051291A Pending JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Country Status (6)

Country Link
US (3) US11986483B2 (enExample)
EP (1) EP4041153A4 (enExample)
JP (2) JP7680653B2 (enExample)
CN (3) CN120284977A (enExample)
AU (2) AU2020361511B2 (enExample)
WO (1) WO2021072063A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7680653B2 (ja) * 2019-10-11 2025-05-21 デクラ ベテリナリー プロダクツ リミテッド ライアビリティー カンパニー 耳用製剤、方法およびデバイス

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078116A1 (en) 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US8003616B2 (en) * 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
UA111147C2 (uk) * 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
PL2802209T3 (pl) 2012-01-10 2021-07-05 Entrx LLC Preparaty do uszu
US9849126B2 (en) * 2013-01-03 2017-12-26 Entrx LLC Sterile otic formulations
EA201591954A1 (ru) * 2013-04-12 2016-04-29 Вайом Байосайнсиз Пвт. Лтд. Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций
JP7680653B2 (ja) * 2019-10-11 2025-05-21 デクラ ベテリナリー プロダクツ リミテッド ライアビリティー カンパニー 耳用製剤、方法およびデバイス

Similar Documents

Publication Publication Date Title
JP2014518275A (ja) 再発性マイボーム腺障害の処置方法およびそれによる再発頻度の減少方法
JP2016510329A5 (enExample)
DK2403503T3 (en) Methods for the treatment of ocular inflammatory diseases
US20080318843A1 (en) Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease
JP2015506983A5 (enExample)
HRP20201307T1 (hr) Upotreba reslizumaba za liječenje umjerene do ozbiljne eozinofilne astme
EP2547325B1 (en) Spray-pumpable composition suitable for topical skin application
AU2016228574A1 (en) Topical compositions comprising a corticosteroid
JP2023546361A5 (enExample)
JPH06128159A (ja) 外用剤
JP2006518382A (ja) 眼の障害に罹患している人を処置するためのステロイドの使用
JP2006518382A5 (enExample)
AU2026201359A1 (en) Otic formulations, methods and devices
DE60121047T2 (de) Pharmazeutische zusammensetzung zur behandlung von phimose mit einem topischen corticosteroid
WO2010109424A1 (en) A medicinal antibacterial and steroids cream comprising chitosan and a process to make it
US8722102B2 (en) Compositions for treatment of skin and ear infections
CA2928606A1 (en) Methods for treatment of postoperative inflammation with reduced intraocular pressure
EP1594511A2 (en) Formulations of glucocorticoids to treat pathologic ocular angiogenesis
JP2024516886A5 (enExample)
IL312514A (en) Corticosteroid reduction in treatment with anti-cd38 antibodies
JP2024527001A5 (enExample)
JP2011503109A5 (enExample)
JP2022508512A5 (enExample)
RU2010154665A (ru) Способ предотвращения использования кортикостероидов
WO2012129365A4 (en) Myelin regeneration with androgens